Clinical Lung Cancer supports inclusion and diversity
Clinical Lung Cancer is a strong supporter of diversity in science, research and medicine, and is a promoter of inclusion. The journal offers an inclusive and supportive publishing environment and stands against all forms of discrimination, bullying and harassment.
The Editorial Team commits to influencing and improving gender, racial and ethnic diversity and inclusion, and geographic representation in lung cancer research by improving these areas within the journal; e.g. the editorial board, guest editors and authors. This commitment is aligned with Elsevier’s broader ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.